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gesponse to CPAP and UPPP in Apnea

Prank J. Zorick, MD,* Timothy Roehrs, PhD,* William Conway, MD,^
Qeorge Potts,* and Thomas Roth, PhD*
Ninety-two consecutive patients wilh obstructive sleep apnea syndrome (OSAS) were studied before
and six weeks after treatment with either nasal continuous positive airway pressure (CPAP) or
uvulopalatopharyngoplasty (UPPP) (n = 46 per group). Assignment of patients to treatment was
based on clinical considerations and patient preference. Patients were assessed hy nocturnal
polysomnography and peiformance on lhe Multiple Sleep Latency Test (MSLT) thefollowing day.
Before treatment, the CPAP and UPPP groups did not differ in sleep-related respiratory disturbance,
oxygenation during sleep, fragmentation of sleep, or the level of excessive daytime sleepiness
indicated by the MSL T. Both treatments produced significant improvemenl on all measures. However,
impi-ovement in UPPP patients was significantly less ctmsistent than that of CPAP patients. To
the e.xtent that UPPP successfully reversed the respiratory disturbance (i.e.. 50% reductton in
respiratory events index), sleep continuity and daytime sleepiness were improved to a degree
comparable to that of patients treated with CPAP. (Heniy Ford Hosp Med J 1990;38:223-6)

bstructive sleep apnea syndrorae (OSAS) is a disorder characterized by frequent, recurrent episodes of upper airway
obstruction during sleep, associated with hypoxemia, bradycardia, and brief cortical arousal to resurae breathing (1). OSAS
presents typically as excessive daytirae sleepiness (EDS), obesity, and heavy snoring, which occurs predorainantiy inraen.In
severe and advanced stages OSAS can lead to life-threatening
cardiac arrhythraias,rightheart failure, high blood pressure, and
functionally incapacitating EDS (2,3). Consequentiy, untreated
OSAS is recognized as a serious and potentially lethal disease
(4).
The tworaostfrequently used treatments of OSAS are nasal
continuous positive airway pressure (CPAP) and uvulopalatopharyngoplasty (UPPP). CPAP is the application of continuous
itive pressure to the airway through an airtight nosemask
, It provides a physical pneumatic splint to the upper airway
ereby maintaining patency during sleep. UPPP is designed to
enlarge the oropharyngeal airspace by excision of redundant
softtissuesof the soft palate, uvula, and posterior lateral pharyngeal wall (6,7). Successful UPPP reduces or eliminates the airflow obstruction that occurs during sleep.
The effectiveness of each of these treatraents has been evaluated independently in a number of case series (8,9). While treatment chosen for a given patient is based on anatomical and medical considerations as well as patient preference, no published
study has corapared changes in the signs and syraptoms of
OSAS following CPAP or UPPP.

O

Methods
Subjects
Study subjects included 92 consecurive patients with OSAS
treated by either CPAP (n = 46) or UPPP (n = 46) (Table 1).
Each patient presented to our Sleep Disorders Center with a his-

He,
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tory of EDS and loud snoring. Diagnosis of OSAS was based on
the diagnostic evaluation described below. Each patient underwent treatment (CPAP or UPPP) and was reevaluated six weeks
later.
Assignraent to treatraent was based on patient preference, anatoraical findings, andraedicalindications. Specifically, patients without oropharyngeal collapse (indicated by the otolaryngologic exaraination) were directed to CPAP treatraent. Patients who were poor surgical risks because of age or other raedical complications also were directed to CPAP. Patients were
otherwise free to select their treatraent. While not randomly assigned to the two treatraent groups, no significant differences
were noted between patients of the two groups in age, body
weight, and sex distribution (Table 1).
Procedure
All patients received a coraplete sleep andraedicalhistory,
physical exaraination, and otolaryngologic examination. The
latter included direct nasopharyngoscopy using a Machida
nasopharyngoscope. Patients were exarained while awake, in
both the upright and supine positions. Upper airway dynamic
changes during the Muellerraaneuverwere observed fiberoptically and patients rated as to site and degree of airway compromise (10).
Noctumal polysoranograra (8 hours) was followed by a Multiple Sleep Latency Test (MSLT) the next day. The nocturnal
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Table 1
Characteristics of the Treatment Groups

Age
Mean
SD
Males
Females
Body mass index*
Mean
SD

CPAP

UPPP

51,67
(10,3)
37
9

47,24
(13,7)
39
7

38.32
(8,49)

35.53
(7.01)

*Body mass index = weight (kg)/height- (em) x 10,000,

Table 2
Treatment Effects on Respiration and Sleep
CPAP
UPPP
Pretreatment Posttreatment Preoperative Postoperative
Respiratory Measures:
Respiratory index
Apnea index
Minuies SaOj
<85%
Sleep Measures:
% Stage 1
% Stage 2
% Stage 3/4
% Stage REM
Daytime Sleepiness:
MSLT average LAT

76,0
(23)
49,0
(26)
12,0
(12)

7.(1
19)
4.(1
(9)
1.0

(6)

71.0
(30)
42.0
(28)
14.0
(16)

43,0
(30)
23.0
(23)
5,0
(8)

57.0
(24)
31,0
(21)
1,0
(3)
10,0
(6)

16,0
(10)
53,0
(11)
9,0
(8)
21,0
(7)

54,0
(21)
33,0
(18)
4,0
(6)
10,0
(5)

42,0
(26)
40.0
(19)
5.0
(7)
13,0
(6)

4,4
(0,9)

10,3
(1,1)

4,1
(1.0)

5.5
(0.9)

Data are means and (standard deviations).

polysoranograra included the central (C3/C4) and occipital (Oz)
EEG, right and left electrooculograras (EOGs), and subraental
and tibialis electrorayograras (EMGs) with continuous ECG recording (11). Respiration was raonitored with a thermistor at
the nose and mouth to detect airflow and by thoracoabdominal
strain gauges to detect respiratory effort (12). Oxygen saturation
was measured continuously by a Biox ear oxiraeter.
Inforraation was recorded by Grass model 78-D or Nihon
Kohden (raodels 4312 and 4212) polygraphs. The Grass polygraphs were calibrated with a pen deflection of 50 pV = 7.5 ram
for the EEG and EOG and 50 )iV = 10.0rarafor the EMG. The
V2 amp low-frequency filter was set at 0.3 Hz with sensitivity x
1 for the EMG. The f i arap high-frequency filter was set at 90
Hz. The Nihon Kohden machines were calibrated at 50 pV =
10.0 mra for the EEG and EOG and at 50 pV = 16.5ramfor the
EMG. The f i amp low-frequencyfilterswere set at 0.3 Hz with
sensitivity x 5 for the EEG and EOG and at 0.003 Hz with sensitivity X 1 for the EMG. The f i amp high-frequency filters were
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set at 70 Hz. All electrode impedances were less than 10,(X)Q
ohms and paper speed was 10 mm/sec.
The MSLT was conducted at 10 AM, 12 PM, 2 PM, and 41^.
following standard procedures (13). Subjects were in bed in,
darkened roora and instructed to try to sleep while EOGs, suk
raental EMG, and EEGs, always including an Oz placemem.
were recorded. The recording was terrainated after 1rainuterf
unarabiguous stage I sleep, after the first signs of stage 2 oi
rapid eye movement (REM) sleep, or after 20 minutes of continuous wakefulness (10).
Six weeks after UPPP, operated patients returned to the sle^
laboratory for follow-up polysoranograra and MSLT. CPAP
patients underwent an adjustment night to determine optimum
CPAP pressure. The home CPAP apparatus (Respironics Sleep
Easy) was then set at the lowest effective pressure to prevent airway obstruction during the 8-hour adjustment night. These patients retumed six weeks later for a polysoranograra while using
the CPAP apparatus, followed the next day by a MSLF without
the apparatus.
All noctumal polysoranograms were scored for sleep stages
according to the standard criteria of Rechtschaffen and Kales
(11). The respiratory tracings were scored for episodes of apnea
(cessation of airflow and/or effort for 10 sec or more) or hypopnea (50% reduction in airflow and/or effort for 10 sec or
more). These were classified as central apneas (cessation of both
oronasal airflow and respiratory effort), obstmctive apneas (cessation of oronasal airflow with continued respiratory effort), or
raixed apneas (episodes with central and obstructive components). The lowest level of oxygen saturation (SaO,) and the frequency and duration of hypoxia (SaOj less than 85%) were recorded.
These outcoraeraeasureswere submitted to two factor mixed
design analyses using the Statistical Analysis System Institute
general linear raodel analysis. Data frora the two treatment
groups deterrained the between-group factor, and pretreatment
versus posttreatment scores represented the within-group factor.
Conservative P levels corrected by the Greenhouse-Geisset
raethod were used for all pretreatraent and posttreatment comparisons. The between-group posthoc comparisons were made
with the Duncan test.

Results
The pretreatraent and posttreatraent measures of sleep-related
respiratory disturbance, oxygenation during sleep, stages of
sleep, and level of EDS (MSLT, average sleep latency in mi"'
utes) are presented in Table 2. Before treatraent, the CPAP and
UPPP patients did not differ in any of these pararaeters. Botli
treatments were associated with significant improvement m
sleep-related respiration and oxygenation. Respiratory eventS'
index (REI) was reduced significantiy (F = 214.68, P < O.OOD'
as was the apnea index (AI) (F = 108.34, P < 0.001). Oxygen^'
tion expressed as minutes of Sa02 < 85% was iraproved signi^^
cantiy (F = 45.84, P< 0.001).
The measures of sleep staging also improved toward norma''
The percentage of light .sleep (stage 1) was reduced (F= 100.83'
P < 0.001) and the percentage of deep slow wave sleep increase"
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36.10. P < 0.001), while the percentages of REM and stage
7 sleep were increased (F = 76.96, P < 0.001; F = 39.77, P <
' OOD- Reduction in the level of daytirae sleepiness (F = 44.46,
0 ^:0.001) was proportional to the iraproved sleep pattems.
fhere was a significant difference in the extent of improvejjjgnt in
treatraent groups. Iraproveraent in UPPP pajjgpts was significantly less than that of CPAP patients on all
pleasures except one. Oxygenation iraproved equally in both
roupS' tint respirationraeasures(REI and AI) were signifi"'antly better with CPAP (F = 38.69, P < 0.001; F = 19.65, P <
n ool)- Each sleep stage measure—stages 1, 2, 3/4, and REM (F
,23.64, P<0.001;F=10.12,P<0.001;F=16.60,P<0.001;F
, 23.15, P < 0.001)—and the level of daytime sleepiness (F =
17 30, P < 0.001) were also improved to a greater extent in the
CPAP group (Table 2).
The statistically different results between treatraents was
due to an inconsistency in patient response to UPPP. Various
criteria used to assess iraproveraent in OSAS include: reduction
of 50% in Al, reduction of 50% in REI, AI < 10, or REI < 10
(10). Comparing these criteria of iraproveraent araong UPPP
patients showed that REI reduction of 50% or greater was assodated with iraproveraenls in all pararaeters coraparable to the
improveraent observed in the CPAP patients.
Comparisons between UPPP responders and nonresponders
(as defined above) and the CPAP patients were analyzed (Table
3). All parameters except that for oxygenation were significantly improved in posttreatraent tests (P < 0.05), with no difference seen between CPAP and UPPP responders, although those
two groups differed frora the UPPP nonresponders. The UPPP
nonresponders did not improve in any sleep, daytirae sleepiness,
or respiration parameter even though they did show iraprovement in oxygenation.
Despite that the criterion of 50% reduction in REIraakesthe
group of UPPP responders coraparable to patients with CPAP,
all criteria for iraproveraent are arbitrary. This is illustrated by
the significant linear relationship (P < 0.05) between reduction
in REI and iraproveraent in EDS asraeasuredby the MSLT in
the UPPP patients ofthis study (Figure).

Discussion
These data show that CPAP is a more uniformly successful
treatment for OSAS than UPPP. CPAP prevents respiratory disturbance during sleep, restoring its continuity and consequently
correcting EDS in all patients. To the extent that UPPP successfully reverses the respiratory disturbance, sleep continuity is improved and daytirae sleepiness norraalized.
These findings extend and replicate our previous research de•nonstrating a relationship between fragmentation of sleep and
EDS in OSAS. Sleep fragraentation refers to very brief (I to 10
^sc) EEG arousals which occur at the terraination of an apnea
episode. The arousals disrupt the continuity of sleep and reduce
restorative capacity which leads to EDS.
CPAP with pressure set toraaintaina patent airway prevents
^Pnea, the consequent EEG arousals, and fragraentation of sleep.
" ftis study the increased episodes of stage 1 sleep seen in
'^S (reflecting the fragmentation of sleep) retumed to normal
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Table 3
Posttreatment Differences Between Groups

CPAP

Respiratory Measures:
Respiratory index
Apnea index
Minutes SaO,
<85%
Sleep Measures:
% Stage 1
% Stage 2
% Stage 3/4
% Stage REM
Daylime Sleepiness:
MSLT average LAT

UPPP

UPPP

Responders

Nonresponders

7.(1
(9)
4.(1
(9)
1.0
(6)

17,0
(13)
9,0
(10)
2.0
(3)

67,0
(19)
37,0
(23)
8,0
(10)

16.0
(10)
53.0
(11)
9.0
(8)
21,0
(7)

27.0
(15)
49,0
(11)
8,0
(9)
15,0
(6)

55.0
(26)
31,0
(21)
2,0
(4)
12,0
(6)

10,3
(l.l)

8,5
(1.1)

3,0
(0.8)

Data are nieans and (standard deviations).
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CHANGE IN RESPIRATORY EVENTS INDEX

Figure—Change in sleep latency on the MSLT before and six
weeks after treatment with UPPP related to the change in re spiratoi-y events index before and after treatment. A significant linear relationship (r = -0.42, P < 0.05) was found.

in all patients with CPAP treatment. Restoration of the continuity of sleep leads to a normalization of daytirae alertness.
Patients receiving UPPP did not iraprove uniforraly. In patients who experienced araarkedreduction in the nuraber of respiratory events, the araount of stage 1 sleep was reduced proportionately. Improveraent in sleep continuity was associated with
iraproveraent in the level of daytirae sleepiness/alertness in such
patients. Such was not the case for patients in whom UPPP was
unsuccessful. The apnea continued as did both the sleep fragmentation and the daytirae sleepiness. This linear relationship
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between daytime sleepiness/alertness and sleep fragmentation
is illustrated in the Figure. Note that the REI indicates the nuraber of arousals and hence the fragraentation of sleep.
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